If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

Share Price is delayed by 15 minutes
Get Live Data
71.60    1.00 (1.42%)
Bid:
71.50
Ask:
71.80
Spread: 0.30 (0.42%)
Market Cap: £183.83m
CRST Live PriceLast checked at - London Stock Exchange

Intraday Crest Nicholson Share Chart

Trading Update

19 Mar 2024 07:00

RNS Number : 3177H
Crest Nicholson Holdings PLC
19 March 2024
 

 

The information contained in this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 which forms part of domestic law in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018

Crest Nicholson Holdings plc

 (the 'Group' or 'Crest Nicholson')

 

AGM

Crest Nicholson Holdings plc is holding its Annual General Meeting ('AGM') at 11:00 am today at the Group's Head Office: 500 Dashwood Lang Road, Bourne Business Park, Addlestone, Surrey KT15 2HJ. This trading update is for the period from 1 November 2023 to 15 March 2024. The Company's FY24 year end is on 31 October 2024.

Current trading

The Group has achieved reservations in line with expectations and delivered a year-to-date open market SPOW rate of 0.44, based on 46 outlets, with reduced activity before Christmas and a stronger performance from mid-January. The SPOW rate for the last eight weeks to 15 March 2024 improved to 0.52. Sale prices achieved have been in line with expectations and cancellations remained at normalised levels. Build activity in the sector continued to operate at a lower level which is now resulting in lower labour costs in some areas. Overall build cost inflation has largely stabilised and at a level lower than prior year.

The Group remains focused on improving customer service and since February 2023 has consistently achieved >90% customer satisfaction rating.

The planning system continues to be challenging. Our strong land portfolio with several quality sites acquired last year places us in a favourable position to mitigate planning delays and support future outlet growth.

Farnham and other legacy sites

Construction at the Farnham development and other legacy sites which are still being completed is progressing largely as planned.

Pre 2019 completed sites

Since the publication of the FY23 results, the Group has become aware of certain build defects predominantly on four sites that were completed prior to 2019 when the Group closed its Regeneration and London divisions. These sites will require remediation over the next three years at an estimated cost of up to £15m. As a result, the Board has decided to appoint third party consultants to provide greater assurance on the adequacy of current provisions around these and other sites completed prior to 2019. A further update will be provided at the Group's interim results in June.

Outlook

The Group continues to focus on optimising value and expects FY24 completions to be in the range of 1,800 to 2,000 homes, with completions weighted approximately 35/65% in favour of the second half of the year, reflecting the opening order book and the low level of reservations in the first two months of the financial year. Sales prices are expected to remain stable in FY24. Net debt at the end of February 2024 is tracking lower than expected as a result of lower build and land spend and this trend is expected to continue in the remainder of the financial year.

The person responsible for arranging the release of this announcement on behalf of the Company is Penny Thomas, Group Company Secretary.

For further information, please contact:

Crest Nicholson

Jenny Matthews, Head of Investor Relations +44 (0) 7557 842720

Teneo

James Macey White / Giles Kernick +44 (0) 207 260 2700

19 March 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSTVSITLIS
Date   Source Headline
13th Mar 20231:48 pmRNSBuilding Safety Contract
13th Mar 202311:07 amRNSHolding(s) in Company
10th Mar 20232:04 pmRNSDirector/PDMR Shareholding
9th Feb 20232:13 pmRNSDirector/PDMR Shareholding
8th Feb 202312:17 pmRNSAnnual Integrated Report and Notice of AGM
31st Jan 20239:40 amRNSHolding(s) in Company
30th Jan 202312:05 pmRNSDirector/PDMR Shareholding
30th Jan 202311:55 amRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSFinal Results
22nd Dec 20229:00 amRNSHolding(s) in Company
20th Dec 20224:56 pmRNSHolding(s) in Company
2nd Dec 202211:56 amRNSDirector Declaration
23rd Nov 20228:45 amRNSHolding(s) in Company
17th Nov 20227:00 amRNSTrading Statement
11th Nov 20224:00 pmRNSHolding(s) in Company
8th Nov 20223:56 pmRNSHolding(s) in Company
31st Oct 202210:37 amRNSHolding(s) in Company
21st Oct 202211:13 amRNSHolding(s) in Company
18th Oct 202210:13 amRNSHolding(s) in Company
17th Oct 20227:00 amRNSBlock listing Interim Review
17th Oct 20227:00 amRNSBlock listing Interim Review
5th Oct 20229:46 amRNSDirector/PDMR Shareholding
3rd Oct 20222:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20221:59 pmRNSDirector/PDMR Shareholding
23rd Sep 20221:59 pmRNSDirector/PDMR Shareholding
13th Sep 20229:32 amRNSDirector/PDMR Shareholding
2nd Sep 20222:09 pmRNSHolding(s) in Company
10th Aug 20223:43 pmRNSHolding(s) in Company
2nd Aug 20222:35 pmRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSHolding(s) in Company
14th Jun 20227:00 amRNSHalf-year Report
27th May 202210:18 amRNSDirectorate Change
20th May 202210:34 amRNSHolding(s) in Company
19th Apr 202210:33 amRNSBuilding Safety Pledge
19th Apr 20229:00 amRNSBlock listing Interim Review
5th Apr 20227:00 amRNSBuilding Safety Pledge
22nd Mar 20222:14 pmRNSResult of AGM
22nd Mar 20227:00 amRNSAGM Statement
10th Mar 20228:17 amRNSDirector Declaration
28th Feb 202210:53 amRNSDirector/PDMR Shareholding
9th Feb 202211:03 amRNSAnnual Integrated Report and Notice of AGM
31st Jan 202210:38 amRNSDirector/PDMR Shareholding
31st Jan 202210:27 amRNSDirector/PDMR Shareholding
28th Jan 20223:02 pmRNSDirector/PDMR Shareholding
19th Jan 202211:38 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSFinal Results
9th Dec 20218:51 amRNSDirector Declaration
18th Nov 20217:00 amRNSTrading Statement
20th Oct 20217:00 amRNSCapital Markets Day
18th Oct 20219:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.